Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Personalized circulating tumor DNA analysis as a predictive biomarker in solid tumor patients treated with pembrolizumab

作者:Scott V. Bratman, S.Y. Cindy Yang, Marco Iafolla, Zhihui Liu, Aaron R. Hansen, Philippe L. Bédard, Stéphanie Lheureux, Anna Spreafico, Albiruni Abdul Razak, Svetlana Shchegrova, Maggie C. Louie, Paul R. Billings, Bernhard Zimmermann, Himanshu Sethi, Alexey Aleshin, Dax Torti, Kayla Marsh, Jenna Eagles, Iulia Cirlan, Youstina Hanna, Derek Clouthier, Scott Lien, Pamela S. Ohashi, Wei Xu, Lillian L. Siu, Trevor J. Pugh · 发表于:Nature Cancer · 年份:2020 · DOI:10.1038/s43018-020-0096-5 · 被引用次数:501 · 研究领域:Cancer Genomics and Diagnostics、Cancer Immunotherapy and Biomarkers、Lung Cancer Treatments and Mutations